Flagship explainer
What drives IMMUNITYBIO, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$351M | FY2025 |
| |
| Income before tax | −$352M | FY2025 |
|
| Operating income | −$256M | FY2025 |
|
| $113M | FY2025 |
| |
| Ending assets | $502M | FY2025 |
|
| Beginning assets | $383M | FY2024 |
|
| −$500M | FY2025 |
| |
| −$489M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001326110-26-000030